- Healthcare is on the edge of a brand new era thanks to personalised medicine – and BESydney has assisted in bringing the 16th annual Human Genome Meeting to Sydney
- The four-day conference will explore the impacts of next generation genomic approaches on medicine and health – with a focus on personalised medicine
- The $10 million Archon Genomics X Prize presented by Medco will highlight the conference -the ground-breaking competition challenging teams of researchers to become the first to rapidly, accurately and economically sequence 100 whole human genomes to a level of accuracy never achieved before. Sydney may well see the first winner of the Prize awarded
- A special closing session to be held on Genomics of Indigenous Populations hopes to launch partnerships that may improve the understanding of genetic relatedness in humans
Healthcare is on the edge of a brand new era thanks to the ever-evolving field of human genome research, and Sydney is gearing up to host the best and brightest in the sector for the 16th annual Human Genome Meeting (HGM2012).
HGM2012, secured with the assistance of Australia’s leading convention bureau, Business Events Sydney (BESydney), will see more than 750 of the world’s leading practitioners, researchers and educators from 50 countries coming together from Sunday 11March to Wednesday 14 March at the Sydney Convention and Exhibition Centre (SCEC) to engage in the increasingly significant topic of ‘Genetics and Genomics in Personalised Medicine’.
The four-day conference will explore the impacts of next generation genomic approaches on medicine and health. The focus of the Meeting will be on personalised medicine – the new wave medical model that tailors healthcare decisions and practices to individuals and has the capacity to predict disease development and even influence decisions about a person’s lifestyle choices. In addition, HGM2012 will discuss the latest developments in preventative medicines, ethics, society, intellectual property, community engagement and more.
Lyn Lewis-Smith, Chief Executive Officer of BESydney, said securing HGM2012 for Sydney posed great opportunities for the city that will span far beyond the economic impact of the tourism dollar generated by the event. “We are thrilled to be working with the Human Genome Organisation (HUGO) Singapore, to host their annual Meeting in Sydney for the first time. The value of holding such an event lies in the ideal of sharing the science and planting the seed for expanding local knowledge, growing networks and assisting in research, funding and development for the medical and science industries in the future.”
“BESydney has been successful in connecting Sydney globally through conventions, conferences, congresses, incentives and business meetings for more than 40 years, and HGM2012 is yet another world conference set to bring long-term benefits to the city.”
The opportunity for collaboration is supported by the Chair of the local organising committee, Professor Ron Trent, commenting: “The local organising committee and I eagerly await the arrival of some of our field’s brightest minds as there is no doubt the meeting in Sydney will lead to relationships, innovations and discussions that will fuel future growth and development in the field. The comprehensive program of plenary lectures, symposia, workshops and poster presentations covers an array of key topics from e-health to economic value in science and population medicine.”
An important international highlight of the conference will be the $10 million Archon Genomics X Prize presented by Medco – the ground-breaking competition challenging teams of researchers to become the first to rapidly, accurately and economically sequence 100 whole human genomes to a level of accuracy never achieved before. One hundred people aged over one hundred have donated the one hundred genomes to be sequenced for this competition – called the Medco 100 Over 100. Since the competition was launched in 2006, no human genome sequence has yet been completed, however, the competition has led to important advances in DNA sequencing technologies. Sydney may well see the first winner of the Prize awarded.
A special closing session to be held on Genomics of Indigenous Populations where engagement of indigenous representatives from the Americas, Asia, Australasia, and the South Pacific, along with involved scientists, are hoping to launch partnerships that may improve the understanding of genetic relatedness in humans and uncover the range of diversity in genotype-phenotype associations.
The 16th HGM2012 was secured by BESydney and the local organising committee for Sydney in 2009 and has been organised by professional conference organiser, ICMS Australasia. This year, HGM2012 coincides with the annual scientific conference Pathology Update 2012, held by The Royal College of Pathologists of Australasia (RCPA) and, for the first time, will collaborate with the RCPA to host a list of joint sessions on Day 1 of the conference.
Among the many Australian and international presenters at HGM2012 will be Professor Ronald Trent, Sydney Local Organising Committee of HGM2012 and Chair of the Human Genetics Advisory Committee (HGAC) – the equivalent of the UK’s Human Genetics Commission – a committee established by the Australian Government to provide continuing high-level advice on current and emerging issues in human genetics. Professor Edison Liu, President of HUGO and Executive Director of the Genome Institute of Singapore will lead the delegation and conference.